Two compounds target drug-resistant brain cancer cells in laboratory… | HappeningNow.news

Health · 8 views

Two compounds target drug-resistant brain cancer cells in laboratory tests

Cancer remains among the most deadly diseases worldwide. Globally, more than 300,000 new cases of brain cancer are reported each year, with glioblastoma, an aggressive form of brain cancer, accounting for over 250,000 deaths.

Source Summary Published 1h 24m ago Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 8 Community interest
Brief read Under 1 min brief 67 words

Summary

Cancer remains among the most deadly diseases worldwide. Globally, more than 300,000 new cases of brain cancer are reported each year, with glioblastoma, an aggressive form of brain cancer, accounting for over 250,000 deaths. The current standard of care involves the use of temozolomide (TMZ), a chemotherapy medication. However, the tumor can be difficult to control because cancer cells evolve to evade the effects of such treatments.

Read original at Medical Xpress

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page